← FDA Drug Approvals (Drugs@FDA)

ERYZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALRA · Approved 1988-06-15

Drug application

FDA Application #

ANDA062758

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYZOLE

Generic name

Erythromycin Ethylsuccinate

Active ingredients

ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL

Dosage form

GRANULE

Route

ORAL

Marketing status

Discontinued

Sponsor

ALRA

First approval

1988-06-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown